arrow
S

Simone Difilippantonio

Frederick National Laboratory for Cancer Research
H指数:30
被引数:5,016

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma

治疗性NAMPT抑制揭示了神经母细胞瘤中可靶向的代谢易损性

2026-08-050
OAAI
The Cyclin C-CDK8/19 Mediator kinase module controls PRCC-TFE3 driven senescence in renal epithelium and tumorigenesis in TFE3-RCC

Cyclin C-CDK8/19介导激酶模块调控PRCC-TFE3驱动的肾上皮细胞衰老及TFE3-RCC中的肿瘤发生。

2026-03-160
OAAI
Expanding Chemical Space of Nucleic Acid Nanoparticles for Tunable Antiviral-Like Immunomodulatory Responses and Potent Adjuvant Activity
2026-01-010
OAAI
A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models

一种CSF-1R抑制剂在血液传播的预临床模型中既可预防又可治疗三阴性乳腺癌脑转移瘤

2025-08-040
OAAI
Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice

通过合成TLR4激动剂与RG1-VLP疫苗联合使用,可在小鼠中实现免疫谱系多样性。

VACCINE
IF3.5
2025-01-011
OAAI
Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia
2024-10-231
OAAI
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
2024-10-120
PRE
Toward a CRISPR- based mouse model of Vhl- deficient clear cell kidney cancer: Initial experience and lessons learned
2024-10-040
OAAI
Gα13 restricts nutrient driven proliferation in mucosal germinal centers
2024-07-180
OAAI
Distinct uptake and elimination profiles for trastuzumab, human IgG, and biocytin-TMR in experimental HER2+brain metastases of breast cancer

trastuzumab,人IgG和biocytin-tmr在实验性乳腺癌HER2脑转移中的不同摄取和消除特征

2024-02-132
OA
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
2023-12-0110
OAAI
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer

错配修复缺陷型结直肠癌的类器官和转移性原位小鼠模型

2023-09-082
OAAI